SiMPore Overview
- Year Founded
-
2007

- Status
-
Private
- Employees
-
19

- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$225K
- Investors
-
7
SiMPore General Information
Description
Developer of nanotechnology designed to offer silicon-based non-porous precision membranes for biomedical and material science applications. The company's products include filters for separating and concentrating biological molecules and nanoparticles, cell culture substrates for growing cells, and electron microscopy grids for preparing and imaging samples at the nanoscale, thereby enabling clients to perform imaging and analysis of nanoscale materials.
Contact Information
Website
www.simpore.comCorporate Office
- 150 Lucius Gordon Drive
- Suite 110
- West Henrietta, NY 14586
- United States
Corporate Office
- 150 Lucius Gordon Drive
- Suite 110
- West Henrietta, NY 14586
- United States
SiMPore Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
11. Grant | 20-Jul-2017 | $225K | Completed | |||
10. Secondary Transaction - Private | 01-Mar-2021 | Completed | Generating Revenue | |||
9. Grant | 06-May-2020 | Completed | Generating Revenue | |||
8. Grant | 01-Sep-2019 | Completed | Generating Revenue | |||
7. Grant | 02-Sep-2019 | Completed | Generating Revenue | |||
6. Grant | 01-Jan-2018 | Completed | Generating Revenue | |||
5. Grant | 01-Aug-2017 | Completed | Generating Revenue | |||
4. Accelerator/Incubator | 15-Dec-2010 | Completed | Generating Revenue | |||
3. Early Stage VC (Series A) | 16-Jun-2010 | $1M | $2.25M | Completed | Generating Revenue | |
2. Early Stage VC | 30-May-2008 | $1.25M | $1.25M | Completed | Generating Revenue |
SiMPore Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A |
SiMPore Comparisons
Industry
Financing
Details
SiMPore Competitors (2)
One of SiMPore’s 2 competitors is Sphere Fluidics, a Venture Capital-Backed company based in Cambridge, United Kingdom.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Sphere Fluidics | Venture Capital-Backed | Cambridge, United Kingdom | ||||
Molecular Devices | Corporate Backed or Acquired | San Jose, CA |
SiMPore Patents
SiMPore Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-11119013-B2 | Extracellular vesicle isolation by nanomembranes | Active | 12-Oct-2018 | ||
US-11635357-B2 | Extracellular vesicle isolation by nanomembranes | Active | 12-Oct-2018 | ||
US-20200116603-A1 | Extracellular vesicle isolation by nanomembranes | Active | 12-Oct-2018 | ||
US-20210372893-A1 | Extracellular vesicle isolation by nanomembranes | Active | 12-Oct-2018 | ||
EP-3837544-A1 | Devices, methods, and kits for sample analysis using microslit filters | Pending | 16-Aug-2018 | G01N1/4077 |
SiMPore Signals
SiMPore Investors (7)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
National Institute of Environmental Health Sciences | Government | |||
National Center for Research Resources | Government | |||
National Heart, Lung, and Blood Institute | Government | |||
National Institute of General Medical Sciences | Government | |||
U. S. National Science Foundation | Government |
SiMPore FAQs
-
When was SiMPore founded?
SiMPore was founded in 2007.
-
Where is SiMPore headquartered?
SiMPore is headquartered in West Henrietta, NY.
-
What is the size of SiMPore?
SiMPore has 19 total employees.
-
What industry is SiMPore in?
SiMPore’s primary industry is Biotechnology.
-
Is SiMPore a private or public company?
SiMPore is a Private company.
-
What is SiMPore’s current revenue?
The current revenue for SiMPore is
. -
How much funding has SiMPore raised over time?
SiMPore has raised $2.25M.
-
Who are SiMPore’s investors?
National Institute of Environmental Health Sciences, National Center for Research Resources, National Heart, Lung, and Blood Institute, National Institute of General Medical Sciences, and U. S. National Science Foundation are 5 of 7 investors who have invested in SiMPore.
-
Who are SiMPore’s competitors?
Sphere Fluidics and Molecular Devices are competitors of SiMPore.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »